Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities (Tables)

9 Months Ended

Sep. 30, 2022

Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investment Securities

Schedule of marketable investment securities, restricted cash and cash equivalents, and other investment securities

	As of
	September 30,		December 31,
	2022		2021
	(In thousands)
Marketable investment securities:
Current marketable investment securities:
Strategic - available-for-sale	$	144	$	152
Strategic - trading/equity		1,010		1,895
Other		101,904		2,973,471
Total current marketable investment securities		103,058		2,975,518
Restricted marketable investment securities (1)		36,044		28,696
Total marketable investment securities		139,102		3,004,214
Restricted cash and cash equivalents (1)		67,670		5,306,072
Other investment securities:
Other investment securities		168,566		150,941
Total other investment securities		168,566		150,941
Total marketable investment securities, restricted cash and cash equivalents, and other investment securities	$	375,338	$	8,461,227

(1) Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash, cash equivalents and marketable investment securities” on our Condensed Consolidated Balance Sheets.

Schedule of fair value measurements

	As of
	September 30, 2022								December 31, 2021
	Total		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3
	(In thousands)
Cash equivalents (including restricted)	$	717,496	$	103,905	$	613,591	$	—	$	7,592,696	$	83,302	$	7,509,394	$	—
Debt securities (including restricted):
Commercial paper	$	52,823	$	—	$	52,823	$	—	$	2,533,875	$	—	$	2,533,875	$	—
Corporate securities		84,617		—		84,617		—		462,999		—		462,999		—
Other		652		—		508		144		5,445		—		5,293		152
Equity securities		1,010		1,010		—		—		1,895		1,895		—		—
Total	$	139,102	$	1,010	$	137,948	$	144	$	3,004,214	$	1,895	$	3,002,167	$	152

Schedule of gains and losses on sales and changes in carrying amounts of investments and other

	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
Other, net:	2022		2021		2022		2021
	(In thousands)
Marketable investment securities - realized and unrealized gains (losses)	$	(485)	$	(1,634)	$	(896)	$	(1,633)
Derivative instruments - net realized and/or unrealized gains (losses) (1)		34,000		(7,380)		92,000		(18,380)
Non-marketable investment securities - gains (losses)		27,054		—		27,427		317
Costs related to early redemption of debt		—		—		(1,149)		(3,587)
Equity in earnings (losses) of affiliates		(570)		424		687		1,957
Other		(2,058)		39,659		(3,805)		39,924
Total	$	57,941	$	31,069	$	114,264	$	18,598

(1) The change in the derivative’s fair value was primarily driven by Level 3 current market data indicative of pricing of similar assets, which resulted in an increase in our estimate of our derivative’s underlying asset value. See above for further information on our valuation of derivative instruments.